Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Aquestive Therapeutics
AQST
$523M
| $827K | ﹤0.01% |
189,669
-55,779
| -23% | -$219K |
|
2652
Soluna Holdings
SLNH
$208M
| $827K | ﹤0.01% |
+4,124
| New | +$828K |
|
2653
Origin Bancorp
OBK
$1.68B
| $826K | ﹤0.01% |
19,500
-5,100
| -21% | -$209K |
|
2654
Aligos Therapeutics
ALGS
$42.2M
| $825K | ﹤0.01% |
+2,128
| New | +$842K |
|
2655
Chord Energy
CHRD
$7.51B
| $825K | ﹤0.01% |
8,300
-5,700
| -41% | -$524K |
|
|
SSY
2656
DELISTED
SunLink Health Systems
SSY
| $825K | ﹤0.01% |
317,484
+5,100
| +2% | +$13.1K |
|
|
CALA
2657
DELISTED
Calithera Biosciences, Inc
CALA
| $825K | ﹤0.01% |
18,930
-17,324
| -48% | -$747K |
|
2658
VOC Energy
VOC
$54.6M
| $823K | ﹤0.01% |
179,207
+23,207
| +15% | +$102K |
|
|
VIVS
2659
VivoSim Labs
VIVS
$1.15M
| $822K | ﹤0.01% |
10,074
-2,767
| -22% | -$252K |
|
|
ERUS
2660
DELISTED
iShares MSCI Russia ETF
ERUS
| $821K | ﹤0.01% |
+17,200
| New | +$774K |
|
2661
Oak Valley Bancorp
OVLY
$288M
| $820K | ﹤0.01% |
46,767
-13,306
| -22% | -$235K |
|
2662
iShares Core S&P 500 ETF
IVV
$908B
| $819K | ﹤0.01% |
+1,900
| New | +$842K |
|
|
BLPH
2663
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $819K | ﹤0.01% |
201,706
-55,366
| -22% | -$231K |
|
2664
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $816K | ﹤0.01% |
15,200
+8,500
| +127% | +$454K |
|
2665
OptimumBank Holdings
OPHC
$117M
| $816K | ﹤0.01% |
157,500
+11,101
| +8% | +$57.8K |
|
2666
Recon Technology
RCON
$2.43M
| $811K | ﹤0.01% |
+15,928
| New | +$922K |
|
|
HALL
2667
DELISTED
Hallmark Financial Services, Inc.
HALL
| $810K | ﹤0.01% |
22,194
-13,836
| -38% | -$587K |
|
2668
Citizens Community Bancorp
CZWI
$204M
| $802K | ﹤0.01% |
58,300
+18,900
| +48% | +$260K |
|
2669
Protara Therapeutics
TARA
$229M
| $802K | ﹤0.01% |
115,900
+64,473
| +125% | +$503K |
|
2670
Spyre Therapeutics
SYRE
$9.03B
| $797K | ﹤0.01% |
4,012
+1,981
| +98% | +$346K |
|
|
VBNK
2671
VersaBank
VBNK
$654M
| $797K | ﹤0.01% |
+72,300
| New | +$795K |
|
2672
Patria Investments
PAX
$1.86B
| $795K | ﹤0.01% |
48,700
+37,100
| +320% | +$603K |
|
2673
AXT Inc
AXTI
$5.17B
| $793K | ﹤0.01% |
+95,200
| New | +$887K |
|
2674
Atea Pharmaceuticals
AVIR
$411M
| $792K | ﹤0.01% |
+22,600
| New | +$627K |
|
2675
Fiverr
FVRR
$324M
| $786K | ﹤0.01% |
4,300
-90,900
| -95% | -$18.3M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.